GCP
HAE icon

GSA Capital Partners’s Haemonetics HAE Stock Holding History

GSA Capital Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,675
Closed -$618K – 1829
2025
Q3 		$618K Buy
+12,675
New +$785K 0.05% 705
2022
Q3 		– Sell
-29,214
Closed -$1.9M – 1663
2022
Q2 		$1.9M Buy
+29,214
New +$1.73M 0.29% 17
2020
Q4 		– Sell
-3,263
Closed -$285K – 1362
2020
Q3 		$285K Buy
+3,263
New +$285K 0.05% 774
2020
Q1 		– Sell
-2,529
Closed -$291K – 1249
2019
Q4 		$291K Sell
2,529
-618
-20% -$74.8K 0.03% 1049
2019
Q3 		$397K Buy
+3,147
New +$399K 0.05% 695
2019
Q2 		– Sell
-8,856
Closed -$775K – 1553
2019
Q1 		$775K Sell
8,856
-5,889
-40% -$536K 0.08% 436
2018
Q4 		$1.48M Sell
14,745
-1,362
-8% -$143K 0.17% 105
2018
Q3 		$1.85M Sell
16,107
-42,834
-73% -$4.43M 0.1% 280
2018
Q2 		$5.29M Buy
58,941
+47,254
+404% +$3.99M 0.26% 23
2018
Q1 		$855K Buy
+11,687
New +$802K 0.05% 763
2017
Q4 		– Sell
-44,210
Closed -$1.98M – 1652
2017
Q3 		$1.98M Buy
44,210
+34,953
+378% +$1.45M 0.14% 158
2017
Q2 		$366K Buy
+9,257
New +$380K 0.02% 1166
2016
Q1 		– Sell
-17,326
Closed -$559K – 1770
2015
Q4 		$559K Sell
17,326
-5,899
-25% -$191K 0.03% 1093
2015
Q3 		$751K Buy
23,225
+5,571
+32% +$210K 0.04% 861
2015
Q2 		$730K Buy
17,654
+1,928
+12% +$81.3K 0.03% 1121
2015
Q1 		$706K Buy
15,726
+8,700
+124% +$364K 0.03% 1153
2014
Q4 		$263K Buy
+7,026
New +$257K 0.02% 1337

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GSA Capital Partners's HAE Position: Q4 2025 in Review

GSA Capital Partners sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 12,675 shares — an estimated $618K sold.

GSA Capital Partners first reported a position in HAE in Q4 2014 and held it in 17 quarters. The position peaked at $5.29M in Q2 2018. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • GSA Capital Partners reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 12,675 Haemonetics shares in Q4 2025, an estimated $618K.
  • GSA Capital Partners first reported a position in Haemonetics in Q4 2014 and held it in 17 quarters.
  • GSA Capital Partners's Haemonetics position peaked at $5.29M in Q2 2018.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.